Akero Therapeutics Logo

Akero Therapeutics

🇺🇸
AKRO
US00973Y1082

Akero Therapeutics is a US-based biopharmaceutical company dedicated to developing novel therapies for metabolic diseases. Focusing on the treatment of nonalcoholic steatohepatitis (NASH) and other liver diseases, Akero Therapeutics is advancing the development of innovative medicines. The company's core expertise lies in the research and clinical testing of treatment approaches to provide patients with much-needed advancements.

Next Quarterly Earnings

Wednesday, November 11, 2026
Expected

Stock Price

Frequently asked questions

When did Akero Therapeutics last report quarterly earnings?

Akero Therapeutics last reported quarterly earnings on 11/12/2025 (Q3 2025).

How do I add the Akero Therapeutics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2025
Estimate:
Actual:

Company Information

Name
Akero Therapeutics
Ticker Symbol
AKRO
ISIN
US00973Y1082
Country
🇺🇸
USA
Sector